×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Future
Yahoo Finance
According to the 2 industry analysts covering Cyclacel Pharmaceuticals, the consensus is that breakeven is near. They anticipate the company to...
1 month ago
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ ...
Morningstar
BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the...
1 month ago
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today?
InvestorPlace
Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering.
1 month ago
Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript
Seeking Alpha
Cyclacel Pharmaceuticals, Inc. (NASDAQ:NASDAQ:CYCC) Q4 2023 Earnings Call Transcript March 19, 2024 4:30 PM ETCompany ParticipantsGrace Kim...
2 months ago
CYCC - Cyclacel Announces Reverse Stock Split
ADVFN Brasil
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapies that target...
1 week ago
Cyclacel Pharmaceuticals Shares Up 72% After Hours on Withdrawal of Offering
MarketWatch
By Josh Beckerman Cyclacel Pharmaceuticals shares rose 72% to $2.34 after hours Monday as the biopharmaceutical company withdrew a filing...
1 month ago
Cyclacel Pharmaceuticals, Inc.'s (NASDAQ:CYCC) Profit Outlook
Simply Wall Street
Consensus from 2 of the American Biotechs analysts is that Cyclacel Pharmaceuticals is on the verge of breakeven. They expect the company to...
2 months ago
Earnings call: Cyclacel Pharmaceuticals reports Q1 2024 results By Investing.com
Investing.com
Cyclacel Pharmaceuticals , Inc. (NASDAQ:CYCC) has provided its first quarter financial results and business updates for the period ending...
3 weeks ago
CYCC Stock Quote Price and Forecast
CNN
Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It uses cell cycle, transcriptional regulation and DNA damage response biology...
4 months ago
Cyclacel Pharmaceuticals Announces Chief Medical Officer Termination - TipRanks.com
Tipranks
Cyclacel Pharmaceuticals (CYCC) has released an update to notify the public and investors about its officers. Mark H. Kirschbaum, M.D. was...
4 months ago